SCHEMBL31423945

SCHEMBL31423945

CC(C)Nc1nc2c(N3CC4CC3C4)c(-c3cn[nH]c3)ncn2n1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.38
PRKD1 Q15139 1/20 0.33
PRKD2 Q9BZL6 1/20 0.33
PIK3CA P42336 1/20 0.30
JAK2 O60674 1/20 0.30
JAK3 P52333 1/20 0.30
PTK2 Q05397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423941 1.00 MAPK8 (0.38) MAPK8PRKD1PRKD2PIK3CAJAK2
SCHEMBL31423913 0.91 AXL (0.30) MAPK8
SCHEMBL31423888 0.90
SCHEMBL31423900 0.90
SCHEMBL31423957 0.82
SCHEMBL31423985 0.82
SCHEMBL31423935 0.82
SCHEMBL31423991 0.82
SCHEMBL31423982 0.82
SCHEMBL31423954 0.82 JAK2 (0.39) JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054386-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed